background image

Paid Clinical Trials West Virginia

Discover 377 paid clinical trials in West Virginia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

Recruiting
PHASE3

Sponsor:

Pfizer

Location:

Lynchburg, Forest, Laurel, Columbiashow 93 more

Code:

NCT04173273

Conditions

Crohn's Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Etrasimod

Placebo

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Recruiting
PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Charlottesville, Bethesda, Gettysburg, Seafordshow 395 more

Code:

NCT04181060

Conditions

Advanced Lung Non-Squamous Non-Small Cell Carcinoma

Metastatic Lung Non-Squamous Non-Small Cell Carcinoma

Recurrent Lung Non-Squamous Non-Small Cell Carcinoma

Stage IIIB Lung Cancer AJCC v8

Stage IV Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bevacizumab

Biospecimen Collection

Computed Tomography

Echocardiography

Magnetic Resonance Imaging

Natural History Study of Exocrine Pancreatic Function in Infants With Cystic Fibrosis (CF)

Recruiting

Sponsor:

Vertex Pharmaceuticals Incorporated

Location:

Richmond, Durham, Morgantown, Akronshow 21 more

Code:

NCT06506773

Conditions

Cystic Fibrosis

Eligibility Criteria

Sex: All

Age: 0 - 6

Healthy Volunteers: Not accepted

Comparing Two Methods to Follow Patients With Pancreatic Cysts

Recruiting

Sponsor:

ECOG-ACRIN Cancer Research Group

Location:

Charlottesville, Richmond, Fairfax, Falls Churchshow 224 more

Code:

NCT04239573

Conditions

Pancreatic Carcinoma

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

Computed Tomography

Endoscopic Ultrasound

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

MILD® Percutaneous Image-Guided Lumbar Decompression: a Medicare Claims Study

Recruiting

Sponsor:

Vertos Medical, Inc.

Location:

La Plata, Leonardtown, Oxon hill, Clintonshow 944 more

Code:

NCT03072927

Conditions

Lumbar Spinal Stenosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MILD

Interspinous Process Decompression

An Open-Label Trial of Repetitive Transcranial Magnetic Stimulation for Opioid Use Disorder

Recruiting

Sponsor:

West Virginia University

Location:

Morgantown

Code:

NCT04157062

Conditions

Opioid-use Disorder

Substance-Related Disorders

Chemically-Induced Disorders

Mental Disorder

Eligibility Criteria

Sex: All

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Repetitive Transcranial Magnetic Stimulation (rTMS)

A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

Recruiting
PHASE3

Sponsor:

BeiGene

Location:

Bethesda, Annapolis, Baltimore, Yorkshow 61 more

Code:

NCT05100862

Conditions

Relapsed/Refractory Follicular Lymphoma

Marginal Zone Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Zanubrutinib

Rituximab

Lenalidomide

Obinutuzumab

ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)

Recruiting
PHASE3

Sponsor:

Chimerix

Location:

Fairfax, Washington, Norfolk, Durhamshow 52 more

Code:

NCT05580562

Conditions

H3 K27M

Glioma

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Dordaviprone (ONC201)

Dordaviprone (ONC201) + Placebo

Placebo

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

Recruiting
PHASE3

Sponsor:

Bellus Health Inc. - a GSK company

Location:

Williamsburg, Norfolk, Rocky Mount, Raleighshow 67 more

Code:

NCT05599191

Conditions

Refractory Chronic Cough

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

BLU-5937

Placebo

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

Recruiting
PHASE3

Sponsor:

Eli Lilly and Company

Location:

Washington, Baltimore, Kingwood, Winston-Salemshow 73 more

Code:

NCT04396574

Conditions

Migraine

Eligibility Criteria

Sex: All

Age: 6 - 17

Healthy Volunteers: Not accepted

Interventions

Lasmiditan